Growth hormone decreases visceral fat and improves cardiovascular risk markers in women with hypopituitarism: a randomized, placebo-controlled study.
about
Role of the GH/IGF-1 axis in lifespan and healthspan: lessons from animal models.Treatment of adult growth hormone deficiency: who, why and how? A reviewIs growth hormone treatment in children associated with weight gain?--longitudinal analysis of KIGS data.The decreased growth hormone response to growth hormone releasing hormone in obesity is associated to cardiometabolic risk factors.Growth hormone deficiency after treatment of acromegaly: a randomized, placebo-controlled study of growth hormone replacement.Fasting levels of high-sensitivity growth hormone predict cardiovascular morbidity and mortality: the Malmö Diet and Cancer studyShort-term, low-dose GH therapy improves insulin sensitivity without modifying cortisol metabolism and ectopic fat accumulation in adults with GH deficiencyCorrelation of increased plasma osteoprotegerin and cardiovascular risk factors in patients with adult growth hormone deficiency.Effects of growth hormone deficiency on body composition and biomarkers of cardiovascular risk after definitive therapy for acromegalyEffect of growth hormone treatment on diastolic function in patients who have developed growth hormone deficiency after definitive treatment of acromegaly.Effects of growth hormone withdrawal in obese premenopausal womenEffects of GH in women with abdominal adiposity: a 6-month randomized, double-blind, placebo-controlled trialGrowth hormone status predicts left ventricular mass in patients after cure of acromegaly.Adult growth hormone deficiency - benefits, side effects, and risks of growth hormone replacementEffects of tesamorelin on inflammatory markers in HIV patients with excess abdominal fat: relationship with visceral adipose reduction.Effect of growth hormone replacement therapy on the quality of life in women with growth hormone deficiency who have a history of acromegaly versus other disorders.Age-related changes in body composition of bovine growth hormone transgenic miceEffects of GH on body composition and cardiovascular risk markers in young men with abdominal obesityRelative growth hormone deficiency and cortisol excess are associated with increased cardiovascular risk markers in obese adolescent girls.Growth hormone receptor expression in human gluteal versus abdominal subcutaneous adipose tissue: Association with body shapeLipid effects of endocrine medications.A systematic review and meta-analysis of the effect of aerobic vs. resistance exercise training on visceral fat.The interrelationship between bone and fat: from cellular see-saw to endocrine reciprocity.Diagnosis and treatment of growth hormone deficiency in adults.Effects of low dose versus high dose human growth hormone on body composition and lipids in adults with GH deficiency: a meta-analysis of placebo-controlled randomized trials.Impact of Growth Hormone on Regulation of Adipose Tissue.Liver fat in adults with GH deficiency: comparison to matched controls and the effect of GH replacement.Prevalence of the metabolic syndrome in moderately-severely obese subjects with and without growth hormone deficiency.Comparative effects of single-mode vs. duration-matched concurrent exercise training on body composition, low-grade inflammation, and glucose regulation in sedentary, overweight, middle-aged men.GH Supplementation Effects on Cardiovascular Risk in GH Deficient Adult Patients: A Systematic Review and Meta-analysis.Insulin resistance, metabolic syndrome and chronic low grade inflammation in Sheehan's syndrome on standard replacement therapy: a case control study.The Immune System in Obesity: Developing Paradigms Amidst Inconvenient Truths.Growth hormone controls lipolysis by regulation of FSP27 expression
P2860
Q24645123-E2CD93B0-765C-4EFB-8415-330BAD52997AQ28278957-F0E7D2E1-7C99-4FD8-AA3E-602BFC4DBEBBQ30805193-BF98FE5E-5A00-4015-8359-087F9B6E6FB5Q33633368-0602095C-74F2-4887-B7F8-1F3912EC8207Q33736166-C78653DB-FEA2-4518-ACC5-0B58317F4298Q34267323-AB1028A9-F675-47E6-AC2B-71F02616E938Q34284698-1B53BD0B-3BDE-4278-951B-2D8EAF6BCCF7Q35643468-75CFC2AC-D8C8-4F0A-9050-91BE10070251Q36004547-A9E8D4EF-9F66-4864-80ED-3CEB704E4970Q36473064-27C7D645-967D-46FF-A1E6-A95BE220DCECQ36652243-03807C16-FB1E-4D05-92A3-34CF5DBE3120Q36837106-C90E679D-1CA7-4EC2-8C3C-D63398152099Q36896880-5FD663A9-48C5-4CDC-BAE1-00D9761182E3Q36898845-17A49BA7-42A4-4443-979D-0037AB0D51AAQ36903976-8AB5175E-721D-469A-8B8F-A312051F1EBEQ36916560-45387228-AE70-417F-B8D5-0554975A81B5Q37125980-65948791-71E3-46BD-A9F7-3555AF1959A7Q37149597-DABF7B64-B3DC-4EB4-8DA9-BBDCD6448ED7Q37315730-FD67E7FC-2C85-451B-B320-413B3EF7751BQ37374694-054F8755-3442-4F95-96F7-5C1AA376E648Q37811982-52BD9CFA-35AA-418C-A3B4-5D22D7598E26Q37939357-BD828757-2471-44D7-8EDD-9CE45D5DE177Q38062322-DFE3B5D5-93B3-4D05-A42D-C7AE185973B0Q38102923-6E468A27-E70D-4C6B-8E71-6DA3E8F794A6Q38210369-DB4E0DF1-7520-4E27-85AD-5FDE3B6F60B0Q39390983-7FAD4549-6D57-4350-A87F-01A8859A6AB4Q39983308-AE0372EE-A9D7-4B4A-9203-F0DA62B11D1DQ43268918-0F13E918-F323-4B78-BB82-629D6BDFCE1FQ47690750-49E6311D-89B0-430E-8303-B8EFB457FCEFQ47962423-E7F833AE-4FE1-4710-8BAC-20E528D0DBD7Q51321723-82F9F59C-B4F2-4E18-84C9-4D3B3B786AE9Q51807137-4F1C6CBD-1BC5-4424-8441-7288AFB3BFF8Q58549791-9ED470E4-2A72-4CAA-A609-C7926A1CAEA3
P2860
Growth hormone decreases visceral fat and improves cardiovascular risk markers in women with hypopituitarism: a randomized, placebo-controlled study.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Growth hormone decreases visce ...... zed, placebo-controlled study.
@ast
Growth hormone decreases visce ...... zed, placebo-controlled study.
@en
type
label
Growth hormone decreases visce ...... zed, placebo-controlled study.
@ast
Growth hormone decreases visce ...... zed, placebo-controlled study.
@en
prefLabel
Growth hormone decreases visce ...... zed, placebo-controlled study.
@ast
Growth hormone decreases visce ...... zed, placebo-controlled study.
@en
P2093
P2860
P356
P1476
Growth hormone decreases visce ...... zed, placebo-controlled study.
@en
P2093
Amber E Schaub
Andrea L Utz
Beverly M K Biller
Catherine Beauregard
Karen K Miller
Lisa Nachtigall
P2860
P304
P356
10.1210/JC.2007-2371
P407
P577
2008-04-01T00:00:00Z